I say zero, but maybe that is because I am hoping they are going to be accepted at the AAIC and will repeat last year...that is announce they are attending end of June, and then wow everyone with data at the AAIC...shortly followed by the partnership details.
I am also hoping the share price is slightly higher due to announcing Phase 2 in Rett syndrome with FDA grants and money from the Rett Syndrome foundation end of this month...or a partner...